Blb&B Advisors, LLC Bristol Myers Squibb CO Transaction History

Blb&B Advisors, LLC

$2.2 Billion
Q3 2025

A detailed history of Blb&B Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Blb&B Advisors, LLC holds 19,151 shares of BMY stock, worth $896,458. This represents 0.04% of its overall portfolio holdings.

Number of Shares

19,151

Previous 19,531 1.95%

Holding current value

$896,458

Previous $904,000 4.54%

% of portfolio

0.04%

Previous 0.04%

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 31, 2025	SELL	$43.31 - $48.98 $16,457 - $18,612	-380 Reduced 1.95%	19,151 $863,000
Q2 2025 Aug 04, 2025	SELL	$44.12 - $59.6 $129,006 - $174,270	-2,924 Reduced 13.02%	19,531 $904,000
Q1 2025 Apr 25, 2025	SELL	$53.9 - $63.11 $58,427 - $68,411	-1,084 Reduced 4.61%	22,455 $1.37 Million
Q4 2024 Jan 28, 2025	SELL	$51.92 - $59.94 $119,104 - $137,502	-2,294 Reduced 8.88%	23,539 $1.33 Million
Q3 2024 Oct 22, 2024	SELL	$39.66 - $51.75 $27,920 - $36,432	-704 Reduced 2.65%	25,833 $1.34 Million

Q2 2024 Jul 26, 2024	SELL	$40.25 - $52.99 $134,354 - $176,880	-3,338 Reduced 11.17%	26,537 $1.1 Million
Q1 2024 Apr 26, 2024	SELL	$47.98 - $54.4 $50,522 - $57,283	-1,053 Reduced 3.4%	29,875 $1.62 Million
Q4 2023 Jan 19, 2024	SELL	$48.48 - $57.85 $55,073 - $65,717	-1,136 Reduced 3.54%	30,928 $1.59 Million
Q3 2023 Oct 24, 2023	SELL	$57.89 - $64.73 $111,611 - $124,799	-1,928 Reduced 5.67%	32,064 $1.86 Million
Q2 2023 Jul 20, 2023	SELL	$63.71 - $70.74 $72,438 - $80,431	-1,137 Reduced 3.24%	33,992 $2.17 Million
Q1 2023 Apr 21, 2023	SELL	$65.71 - $74.53 $92,848 - $105,310	-1,413 Reduced 3.87%	35,129 $2.43 Million
Q4 2022 Jan 17, 2023	SELL	$68.48 - $81.09 $157,640 - $186,669	-2,302 Reduced 5.93%	36,542 $0
Q3 2022 Oct 14, 2022	SELL	$0.13 - $76.84 $120 - $71,384	-929 Reduced 2.34%	38,844 $2.76 Million
Q2 2022 Jul 18, 2022	SELL	$72.62 - $79.98 $270,872 - $298,325	-3,730 Reduced 8.57%	39,773 $3.06 Million
Q1 2022 Apr 20, 2022	SELL	$61.48 - $73.72 $225,754 - $270,699	-3,672 Reduced 7.78%	43,503 $3.18 Million
Q4 2021 Jan 21, 2022	SELL	$53.63 - $62.52 $634,067 - $739,173	-11,823 Reduced 20.04%	47,175 $2.94 Million
Q3 2021 Oct 19, 2021	BUY	$59.17 - $69.31 $221,473 - $259,427	3,743 Added 6.77%	58,998 $3.49 Million
Q2 2021 Jul 20, 2021	SELL	$61.91 - $67.42 $71,506 - $77,870	-1,155 Reduced 2.05%	55,255 $3.69 Million
Q1 2021 Apr 19, 2021	SELL	$59.34 - $66.74 $711,427 - $800,145	-11,989 Reduced 17.53%	56,410 $3.56 Million
Q4 2020 Jan 19, 2021	SELL	$57.74 - $65.43 $258,328 - $292,733	-4,474 Reduced 6.14%	68,399 $4.24 Million
Q3 2020 Oct 20, 2020	SELL	$57.43 - $63.64 $267,221 - $296,116	-4,653 Reduced 6.0%	72,873 $4.39 Million
Q2 2020 Jul 16, 2020	SELL	$54.82 - $64.09 $232,217 - $271,485	-4,236 Reduced 5.18%	77,526 $4.56 Million
Q1 2020 Apr 21, 2020	BUY	$46.4 - $67.43 $8,630 - $12,541	186 Added 0.23%	81,762 $4.56 Million
Q4 2019 Jan 21, 2020	SELL	$49.21 - $64.19 $164,509 - $214,587	-3,343 Reduced 3.94%	81,576 $5.24 Million
Q3 2019 Oct 22, 2019	BUY	$42.77 - $50.71 $8,639 - $10,243	202 Added 0.24%	84,919 $4.31 Million
Q2 2019 Jul 29, 2019	SELL	$44.62 - $49.34 $38,685 - $42,777	-867 Reduced 1.01%	84,717 $3.84 Million
Q1 2019 Apr 19, 2019	SELL	$45.12 - $53.8 $179,983 - $214,608	-3,989 Reduced 4.45%	85,584 $4.08 Million
Q4 2018 Jan 17, 2019	SELL	$48.76 - $63.23 $225,661 - $292,628	-4,628 Reduced 4.91%	89,573 $4.66 Million
Q3 2018 Oct 12, 2018	SELL	$55.19 - $62.25 $13,521 - $15,251	-245 Reduced 0.26%	94,201 $5.85 Million
Q2 2018 Jul 11, 2018	SELL	$50.53 - $62.98 $59,372 - $74,001	-1,175 Reduced 1.23%	94,446 $5.23 Million
Q1 2018 Apr 09, 2018	BUY	$59.92 - $68.98 $90,359 - $104,021	1,508 Added 1.6%	95,621 $6.05 Million
Q4 2017 Jan 16, 2018	SELL	$59.94 - $65.35 $13,366 - $14,573	-223 Reduced 0.24%	94,113 $5.77 Million
Q3 2017 Oct 16, 2017	BUY	$55.23 - $63.74 $5.21 Million - $6.01 Million	94,336	94,336 $6.01 Million

Others Institutions Holding BMY

# of Institutions

2,679

Shares Held

1.58B

Call Options Held

28.2M

Put Options Held

28.4M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $99.5B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Blb&B Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Blb&B Advisors, LLC with notifications on news.

Account

Blb&B Advisors, LLC Bristol Myers Squibb CO Transaction History